Dosing regimen for anti-DLL3 agents
The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-D...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YAGO, MARC ANTHONY LIAO, MICHAEL HASHEMI SADRAEI, NOOSHIN SMIT, MARIE-ANN DAMIETTE UPRETI, VIJAY VISHESH NGARMCHAMNANRITH, GATAREE SOMAN, NEELESH MINOCHA, MUKUL SHETTY, ADITYA |
| description | The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202128762A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202128762A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202128762A3</originalsourceid><addsrcrecordid>eNrjZFB2yS_OzEtXKEpNz8xNzVNIyy9SSMwrydR18fExVkhMT80rKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGRoZGFuZmRo7GxKgBAI3xJbY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dosing regimen for anti-DLL3 agents</title><source>esp@cenet</source><creator>YAGO, MARC ANTHONY ; LIAO, MICHAEL ; HASHEMI SADRAEI, NOOSHIN ; SMIT, MARIE-ANN DAMIETTE ; UPRETI, VIJAY VISHESH ; NGARMCHAMNANRITH, GATAREE ; SOMAN, NEELESH ; MINOCHA, MUKUL ; SHETTY, ADITYA</creator><creatorcontrib>YAGO, MARC ANTHONY ; LIAO, MICHAEL ; HASHEMI SADRAEI, NOOSHIN ; SMIT, MARIE-ANN DAMIETTE ; UPRETI, VIJAY VISHESH ; NGARMCHAMNANRITH, GATAREE ; SOMAN, NEELESH ; MINOCHA, MUKUL ; SHETTY, ADITYA</creatorcontrib><description>The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed.</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210801&DB=EPODOC&CC=TW&NR=202128762A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210801&DB=EPODOC&CC=TW&NR=202128762A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAGO, MARC ANTHONY</creatorcontrib><creatorcontrib>LIAO, MICHAEL</creatorcontrib><creatorcontrib>HASHEMI SADRAEI, NOOSHIN</creatorcontrib><creatorcontrib>SMIT, MARIE-ANN DAMIETTE</creatorcontrib><creatorcontrib>UPRETI, VIJAY VISHESH</creatorcontrib><creatorcontrib>NGARMCHAMNANRITH, GATAREE</creatorcontrib><creatorcontrib>SOMAN, NEELESH</creatorcontrib><creatorcontrib>MINOCHA, MUKUL</creatorcontrib><creatorcontrib>SHETTY, ADITYA</creatorcontrib><title>Dosing regimen for anti-DLL3 agents</title><description>The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB2yS_OzEtXKEpNz8xNzVNIyy9SSMwrydR18fExVkhMT80rKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGRoZGFuZmRo7GxKgBAI3xJbY</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>YAGO, MARC ANTHONY</creator><creator>LIAO, MICHAEL</creator><creator>HASHEMI SADRAEI, NOOSHIN</creator><creator>SMIT, MARIE-ANN DAMIETTE</creator><creator>UPRETI, VIJAY VISHESH</creator><creator>NGARMCHAMNANRITH, GATAREE</creator><creator>SOMAN, NEELESH</creator><creator>MINOCHA, MUKUL</creator><creator>SHETTY, ADITYA</creator><scope>EVB</scope></search><sort><creationdate>20210801</creationdate><title>Dosing regimen for anti-DLL3 agents</title><author>YAGO, MARC ANTHONY ; LIAO, MICHAEL ; HASHEMI SADRAEI, NOOSHIN ; SMIT, MARIE-ANN DAMIETTE ; UPRETI, VIJAY VISHESH ; NGARMCHAMNANRITH, GATAREE ; SOMAN, NEELESH ; MINOCHA, MUKUL ; SHETTY, ADITYA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202128762A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YAGO, MARC ANTHONY</creatorcontrib><creatorcontrib>LIAO, MICHAEL</creatorcontrib><creatorcontrib>HASHEMI SADRAEI, NOOSHIN</creatorcontrib><creatorcontrib>SMIT, MARIE-ANN DAMIETTE</creatorcontrib><creatorcontrib>UPRETI, VIJAY VISHESH</creatorcontrib><creatorcontrib>NGARMCHAMNANRITH, GATAREE</creatorcontrib><creatorcontrib>SOMAN, NEELESH</creatorcontrib><creatorcontrib>MINOCHA, MUKUL</creatorcontrib><creatorcontrib>SHETTY, ADITYA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAGO, MARC ANTHONY</au><au>LIAO, MICHAEL</au><au>HASHEMI SADRAEI, NOOSHIN</au><au>SMIT, MARIE-ANN DAMIETTE</au><au>UPRETI, VIJAY VISHESH</au><au>NGARMCHAMNANRITH, GATAREE</au><au>SOMAN, NEELESH</au><au>MINOCHA, MUKUL</au><au>SHETTY, ADITYA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dosing regimen for anti-DLL3 agents</title><date>2021-08-01</date><risdate>2021</risdate><abstract>The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202128762A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Dosing regimen for anti-DLL3 agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A03%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAGO,%20MARC%20ANTHONY&rft.date=2021-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202128762A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |